Dear Colleagues and Friends,
It is with great enthusiasm that I welcome you to The Journal of Diagnostic and Theranostic Imaging (The JODTi), where “In Every Frame, We Transform The Care.” As Editor-in-Chief, I am honored to lead this international, open-access, peer-reviewed platform dedicated to advancing knowledge and innovation across the spectrum of diagnostic imaging and theranostic therapies.
Our Mission
Our mission is simple yet profound: to provide a trusted space where groundbreaking research, clinical advancements, and educational resources converge to inspire and inform the global scientific community. We uphold the highest standards of quality, transparency, and accessibility, ensuring that every contribution makes a real-world impact.
What Sets Us Apart
- Unmatched Speed & Impact: We aim to redefine rapid communication in our field. Authors receive a first decision in an average of 3 days, complete peer review in 15 days, and online publication within 30 days of acceptance—so your discoveries reach readers without delay.
- Open Access & Global Reach: We believe in the free exchange of knowledge. All our content is immediately and freely available to researchers and practitioners worldwide, amplifying citation and fostering an inclusive, international dialogue.
- Rigorous Peer Review: Our streamlined editorial process guarantees scientific integrity while maintaining remarkable turnaround times—balancing speed with depth.
- Real-Time Tracking & Expert Feedback: Monitor your manuscript’s progress from submission through DOI assignment, supported by prompt, constructive reviewer comments.
- Ethical & Inclusive Culture: We embrace gender-neutral language, strict ethical standards, and a collaborative spirit that values diverse perspectives and partnerships.
Core Areas of Interest
We welcome submissions across a broad spectrum, including but not limited to:
- PET/CT, SPECT/CT, PET/MRI, and novel radiopharmaceuticals (e.g., Lu-177, I-131)
- Artificial intelligence and machine learning applications in imaging
- CT, MRI, ultrasound, fluoroscopy, and hybrid operating-room technologies
- Dosimetry, radionuclide therapy, and image-guided interventional systems
Whether you are an established investigator or an emerging scholar, you will find in The JODTi a supportive editorial team and a vibrant community eager to engage with your work. I encourage you to explore our content, connect with peers, and consider submitting your valuable research. Together, let us shape the future of diagnostic and theranostic imaging with both excellence and unprecedented speed.

Warm regards,
Fatih BATI, MD
Editor-in-Chief
The Journal of Diagnostic and Theranostic Imaging
Department of Nuclear Medicine, Samsun University Faculty of Medicine
editor@thejodti.com | https://thejodti.com/
